Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction

The introduction of multiple new pharmacological agents over the past three decades in the field of heart failure with reduced ejection fraction (HFrEF) has led to reduced rates of mortality and hospitalizations, and consequently the prevalence of HFrEF has increased, and up to 10% of patients progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vishram-Nielsen, Julie K. K., Tomasoni, Daniela, Gustafsson, Finn, Metra, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820365/
https://www.ncbi.nlm.nih.gov/pubmed/35113350
http://dx.doi.org/10.1007/s40265-021-01666-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820365/
https://www.ncbi.nlm.nih.gov/pubmed/35113350
http://dx.doi.org/10.1007/s40265-021-01666-z

Ejemplares similares